Publication Policies
International Journal of Experimental Research and Review (IJERR, www.iaph.in, e-ISSN: 2455-4855) is a tri-annual multidisciplinary online journal that aims at promoting scientific research and science communication among scientific readers and researchers as well as to enhancing the knowledge base encompassing the latest trends and developments in Basic Sciences (Physics, Chemistry, Mathematics, Earth Science, Astronomy & Life Sciences), Applied Sciences (Engineering, Medicine, Agriculture & Environmental Science) and Allied Disciplines including Computer, Technology, Management, Health and Medical Sciences, Nutrition, Botany, Zoology, Forestry, Fishery, Sericulture, Apiculture, Pharmacology, Bioinformatics, Geography, Educational Statistics and Social Sciences (Psychology, Sociology, Economics, Anthropology). The journal uses a double-blind peer-review process and periodically, the IJERR releases special issues on specific themes of interest. IAPH is dedicated to upholding high moral principles throughout the entire publication process by ensuring a fair evaluation policy and preventing plagiarism. Submitted articles are evaluated and reviewed by qualified editorial board members and/or invited expert reviewers in the relevant subject area. When submitting the manuscript to the online journal system, it is necessary to provide a Cover letter cum Declaration Form in which the author should focus on the subjects and mention specific research fields. This input is extremely helpful because it enables editors to simplify their responsibility of ensuring appropriate expertise. From a variety of sources and subject-matter experience, editors search for relevant possible reviewer names. Recommendations from subject-matter experts often guide editors in determining whether a submission should be accepted, revised, or rejected. Reviewers could provide significant advice on these decisions.
IJERR does not have Committee of Publication Ethics (COPE) registration. Nonetheless, it adheres to COPE's best practices and welcomes the inputs of authors, reviewers, and editorial board members at each and every step of the publication process thus maintaining the highest standards of academic integrity and ethics as promoted by COPE (https://publicationethics.org/search?query=guidance+Guidelines&urlfield=).
IJERR editorial office closely monitors technological concerns, such as plagiarism, fabrication, and falsification. The journal encourages author(s) to submit manuscripts along with text similarity percentages. Furthermore, the editorial office uses Turnitin software to verify the similarities. Other significant aspects pertaining to various malpractice categories are explained in detail in IJERR's Statement on Publication Ethics & Malpractice.
Contents:
(A) Publication Ethics and Malpractice Statement:
(a) Author(s) and Authors’ Responsibilities:
(b) Editorial Board & Their Responsibilities:
(c) Publisher’s Responsibilities:
(d) Reviewers’ Responsibilities:
(e) Publication Ethics:
(f) Handling of Misconduct:
(I) Plagiarism:
(II) Fabrication:
(III) Falsification:
(IV) Authorship Issues:
(V) Conflict of Interest:
(VI) Manipulation of Citations:
(VII) Violation of Research Ethics:
(B) Authorship and Contributorship Policy:
(C) Complaints and Appeals Policy:
(D) Conflicts of interest/ Competing interests:
(E) Data and Reproducibility:
(F) Post-Publication Discussions and Corrections:
(G) Intellectual Property Policy:
(I) Copyright & Access Policy:
(II) License Policy:
(III) Ownership and Management:
(H) Additional Archiving, Abstracting & Indexing:
(I) Repository Policy :
(J) Advertising Policy:
(A) Publication Ethics and Malpractice Statement:
Establishing clear ethical standards for all the stakeholders in the publishing process including the author(s), editors, reviewers, and publishers is essential.
IJERR published by the International Academic Publishing House (IAPH) is dedicated to the following best practices on ethical matters, errors and retractions. One of the key duties of the editorial board is to prevent instances of publication malpractice. Any kind of unethical behaviour is unacceptable, and IAPH does not tolerate plagiarism in any form.
(a) Author(s) and Authors’ Responsibilities:
By submitting a manuscript to IJERR, the author(s) guarantee that the manuscript is the result of their original research or review work and that it has not been previously published or is currently under consideration for publication elsewhere. They also guarantee that any ideas and/or words in the text that are not their own have been appropriately credited via citations and/or quotations.
#The identities of the author(s) are kept hidden during the review process. Editors and reviewers are required to treat manuscript(s) with the utmost confidentiality.
#The authors are advised to avoid copying and pasting while preparing the manuscript(s).
#Author(s) must prepare their manuscripts in accordance with IJERR's criteria for consideration for processing leading to publication.
#The manuscript(s) should provide enough information and up-to-date references to allow others to duplicate the work. Review articles should be truthful, impartial, and complete, with 'opinions' or 'perspectives' explicitly identified as such. False or erroneous remark(s) may be regarded as unethical behaviour/malpractice and, as a result, are unacceptable.
#Submitted manuscript(s) must demonstrate originality in idea and substance.
#When a substantial mistake is discovered in a published article, editor(s) and/or the publisher should be informed immediately. If an erratum, addendum, corrigendum, or retraction of the manuscript is found to be appropriate or required, the author(s) must work with the journal to get it published.
#Accurate citations and references to particular papers, authors, and publications are anticipated during the manuscript preparation process.
#In order to improve the work, author(s) must acknowledge and rectify the errors taking into account the recommendation(s) of the reviewers and/or editor(s).
# Whatever sources are accessed and utilized throughout the research must be acknowledged in the manuscript for publication.
#All co-authors must have viewed and agreed to the final version of the manuscript prior to submission to IJERR for publication, and the same must be declared by the corresponding author(s).
#If the research includes material substance(s), method(s), or equipment(s), the author(s) must explicitly describe any possible hazard(s) connected with their usage in the manuscript.
#All sources of funding/support/grant must be disclosed in the manuscript.
#Once sufficient evidence has been uncovered to indicate any misconduct on the part of any of the author(s), the iaapropriate behaviour is nitified and an opportunity is given to defend the same. If the author(s) cannot adequately address the case, the paper may be rejected/retracted/deleted from the journal website.
#The author(s) must keep accurate records of any data related to their manuscripts and supply/provide access to any such data upon reasonable request. Such data may be submitted to adequate repository for sharing and further use by others, when acceptable and/or approved by the employer, funding organisation, etc.
(b)Editors’ Responsibilities:
#The Editorial Board of IJERR comprises of highly qualified and established researchers from a wide range of scientific fields, and subject-specific experts are invited from time to time depending on individual needs. Editors are in entitled to take a call whether or not an article submitted to IJERR should be published, and the journal's policies govern them in doing so. Co-Editors-in-Chief are responsible for making publishing decisions in coordination with the Associate Editors, and other members of the Editorial Board and reviewers either independently or jointly.
#The Editors may are also bound by lthe egal frameworks in line with IJERR’s policies on copyright infringement, plagiarism, and other issues.
#All manuscripts are evaluated and approved entirely based on their academic merit, without any commercial consideration(s).
#Editors are required to assess the manuscript(s) exclusively based on its merit, regardless of the author(s)' colour, gender, sexual orientation, religious belief, ethnicity, citizenship, or political affiliation.
#Information about submitted manuscripts are not shared with anyone other than the author(s), reviewer(s), editorial advisor(s) and the publisher, as considered suitable by the Editors.
#A conflict of interest occurs when author(s)’ or reviewer(s)’ financial and/or other personal interests have potential to impair or influence any professional judgement and/or impartiality. To minimize the bias, any conflict of interest relevant to the work must be declared by the author(s), reviewer(s), and/or editorial staff(s) including financial and personal ties (if any) that can interfere with the interpretation of the work.
#Any Editor having a conflict of interest stemming from competing, collaborative, and/or other ties or affiliations with any of the author(s), corporation(s), and/or institution(s) involved should not urge other editors/reviewers/editorial advisor(s) to access any manuscript(s).
#Without the author's explicit written authorization, unpublished materials described in a submitted paper should not be used by any editor in their study.
#Wherever possible, the Editors should seek clarification from the author(s) regarding the approval of the institutional ethics committee and/or review board for the experimental finding(s) in question.
#In collaboration with the publisher, the Editors are required to assume responsibility for any ethical concern(s) arising out of any submitted manuscript(s) and/or published paper(s). Such measures typically entail contacting the manuscript or paper's author(s) and giving due consideration to the respective complaint(s) or claim(s) made in this regard. Additional communication(s) with relevant institution(s) may also be required to address the issue(s). If the complaint is upheld, the publication of a correction, retraction, expression of concern, or other note, as appropriate, is published even if it is discovered years after publication.
(c) Publisher’s Responsibilities:
# The International Academic Publishing House (IAPH) owns the International Journal of Experimental Research and Review (IJERR). The IAPH will ensure that seamless procedures are followed to achieve the aforementioned requirements.
#More comprehensive concerns pertaining to publishing ethics are raised from time to time by the IJERR, which brings them to the attention of journal editors, editorial boards, reviewers, and authors.
#The publisher shall take all relevant actions in situations of claimed or confirmed scientific misconduct, fraudulent publishing, or plagiarism. This might involve publishing an erratum, addendum, explanation, or, in the most serious cases, retraction of the published work if considered suitable.
#The publisher will make reasonable efforts to detect and prevent publishing manuscripts wherein research misconduct is suspected or has occurred and will not promote or tolerate any such misconduct if it comes to the attention.
#All the articles are published with the understanding that the author(s) are solely responsible for the statement(s) and opinion(s) stated therein and that their publication do(es) not indicate that such of the statements and/or opinions represent the editor's or publisher's views in this matter.
#Any and all intellectual property rights are explicitly disclaimed. Without the copyright holder's express permission, no portion of the work may be duplicated or used in any form, electronic or mechanical, including photocopying, recording, or any information storing and retrieval.
(d) Reviewer(s)’ Responsibilities:
The editor(s) are able to make more informed editorial decisions with the support of peer reviewers, and the author(s) can receive feedback on how to improve their work through editorial correspondence.
#Reviewers are required to finish their reviews quickly while yet keeping a high level of professionalism. Reviewers must promptly notify the editor if they are unable to complete the assignment by the due date.
#The same norms of secrecy that editors are required to follow must likewise be followed by the reviewers. Unless specifically instructed to do so by the editor, they must not disclose the contents of the manuscript to anyone.
#Reviewing of manuscripts should be done impartially and objectively, without criticizing the author(s) personally. Reviewers should state their opinions clearly and provide reasons to back them up.
#Reviewers are expected to bring attention to any pertinent published work that the author(s) might have missed. Citations are required whenever an assertion is made that a particular observation, derivation, or argument has been previously recorded. While reviewing a manuscript, reviewers should also let the editor know if they see any major overlaps or similarities with previously published papers.
#Reviewers are expected to refrain from assessing manuscripts if they have any affiliations, whether it be with the authors, companies, or institutions involved, that could potentially constitute a conflict of interest. This includes relationships that are either collaborative or competing in nature.
#Application of Generative AI: Any reviewer who accepts an invitation to evaluate a manuscript must maintain the strictest confidentiality. Since using generative AI tools to process submitted manuscripts could compromise data privacy rights, infringe upon author(s)' private and sensitive information, and violate author(s)' rights to secrecy, reviewers should refrain from doing so.
(e)Publication Ethics:
(I)Human Rights & Ethics:
#Each investigator is required to conduct the study within a suitable ethical framework. In accordance with the misconduct policy, editors may reject a manuscript and/or get in touch with the author(s) institution or ethics committee if there is any reason to believe that the work was not conducted within a suitable ethical context. Authors should ensure that human subjects have provided prior informed consent, respecting their privacy and the same is certified/approved by a suitable ethics committee/review board. All manuscripts reporting such research must include a statement mentioning the name of the ethics committee along with the approval reference number. Any exemption from ethical requirements should also be mentioned specifically in the manuscript together with appropriate rationale. Editor(s) should be provided access to additional data and supporting documents upon request.
#Authors must ensure that any study involving human or animal subjects adheres to relevant local, national, and institutional guidelines and requirements e.g., WMA Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/, https://www.med.or.jp/dl-med/wma/helsinki2013e.pdf), NIH Policy on the Use of Laboratory Animals (https://grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animals.pdf, https://olaw.nih.gov/policies-laws/phs-policy.htm), European Animal Research Association (https://www.eara.eu/animal-research-law) and that appropriate approval from the ethics committee and/or review boards have been sought and obtained.
#Author(s) of studies involving human subjects classified by race, ethnicity, national or social origin, gender, sexual orientation, religion, political or other beliefs, age, illness, (dis)ability, socioeconomic status, or other socially constructed or socially significant identifiers should:
*Clearly explain how they classify human populations
*Describe categories as thoroughly as the study protocol permits
*Explain their definitions and category selections, mentioning, for instance, whether their funding agency required any categorization requirements
*Describe whether (and if so, how) their analyses accounted for confounding variables
In the Material and Methods section of the submitted manuscript, ethical certification/permission/approval reference number must be prominently mentioned.
(II)Clinical trial:
When a new technique or tool is applied in a clinical context, like in a case study or technical advancement, author(s) must clearly explain in the manuscript why they believe that the new technique or tool is better suited to the patient's clinical need than standard clinical practice. Clinical trials should be certified by an appropriate ethics committee/review board that prior informed consent and participants' privacy etc. should be strictly maintained. It is expected of author(s) to obtain informed patient consent and ethics committee/review board approval prior to the trial of any new technology or procedure in an experimental setting if there was no obvious clinical benefit based on clinical necessity before treatment.
Registration is required for all interventional trials prior to the first participant being enrolled. Any publicly accessible database that satisfies the minimal 24-item trial registration dataset (https://www.who.int/clinical-trials-registry-platform/network/who-data-set, https://clinicaltrials.gov/), or a primary register of the WHO International Clinical Trials Registry Platform (ICTRP, (https://trialsearch.who.int/) must have trial registration records. In the Material and Methods section of the submitted manuscript, the trial number must be prominently mentioned.
(III)Vulnerable population:
Participants (or their parent or guardian in the case of children under 16) should provide prior informed consent for participation in the study for any research involving human subjects, and the submitted manuscript should acknowledge the same. The participants (or their parents or legal guardians in the case of children under 16) must provide written informed consent for the publication of any manuscript that contains information, photos, or videos pertaining to specific participants. A statement to this effect should also be included in the submitted manuscript. Participants’ next of kins must be contacted for permission to publish if the participant has passed away. Editor(s) must be provided access to the documentation upon request, and it will be kept private. Consent for the publication of photos may not be necessary for situations when the images are completely unidentified and the text contains no information about the individuals featured. The Editor(s) have the last say over whether consent is necessary for any such publication. In the Material and Methods section of the submitted manuscript, the details of vulnerable population must be prominently mentioned.
(IV)Animal Rights & Ethics:
Submitted manuscript(s) must include a statement outlining adherence to pertinent guidelines and/or ethical permission(s) from animal ethics consent/review board along with the name of the ethics committee/review board and approval reference number. Submitted manuscript(s) should also specify whether a study has been exempted from ethical approval requirements, including the name of the ethics committee/review board that granted the exemption and the justification(s) for the same. Animal welfare concerns should be considered by the authors, and the editor retains the authority to reject any publication, particularly if the study used procedures that deviate from well-recognized standards for animal studies. Occasionally, editor(s) may seek further information by getting in touch with the ethics committee/review board.
The corresponding author(s) and/or other co-author(s) are required to verify that all experiments conducted on live vertebrates and/or higher invertebrates were carried out in compliance with applicable rules and regulations for primary research publications published in IJERR. A statement indicating the institutional and/or licensing committee that approved the experiments, together with other pertinent information, must be included in the manuscript. It is necessary to mention an animal's sex and other traits that could affect the outcome. Where housing and husbandry details are likely to affect experimental outcomes, they must be disclosed. When recording animal experiments, advise adherence to ARRIVE 2.0 reporting requirements (published on July 14, 2020 in PLOS Biology, (https://doi.org/10.1371/journal.pbio.3000411) is required.
For further advice on veterinary best practices for animal anesthesia and euthanasia, adherence to the American Veterinary Medical Association's (AVMA) 2020 Guidelines (https://www.avma.org/resources-tools/avma-policies/avma-guidelines-euthanasia-animals) are recommended. Ethical permission and reference number must be clearly stated in the Material and Methods section of the manuscript.
(V) Institutional Review Board (IRB) Approval Policy:
#Activities involving "human subjects" and endangered animals for any type of research must be reviewed and approved by the Institutional Review Board (IRB) of the research facility where the work has been done.
#IRB is in charge of deciding whether research proposals and activities conform to these definitions and whether IRB review and approval are necessary.
#A grant or contract supporting the research, data collection forms, and other materials (such as assessments, questionnaires, etc.) to be used in the project should all be included with the Research with Human Subjects Determination Form in order to receive an official determination of whether a project involves human subjects. Informal inquiries regarding the possibility of needing IRB review and approval do not need submitting the Determination Form.
#The Form with the signed/dated determination will be returned to the Investigator as formal documentation once the IRB Analyst has made their decision. The specifics of the IRB statement must be made clear in the Material and Methods section of the manuscript.
(VI) Plant Rights & Ethics:
#Institutional, national, and/or international norms must be followed while taking up experimental plant research. Field research must also follow institutional, national, and/or international criteria, and the necessary permits and/or permissions must be secured before work can begin.
Whether produced or wild, experimental research and field studies involving plants must follow applicable institutional, national, and international regulations and norms (https://publicationethics.org/). A statement outlining the licenses and/or permissions acquired for the collecting of plant or seed specimen should be included in manuscripts reporting on plant research. It is recommended that authors adhere to the convention on the trade in endangered species of wild fauna and flora (https://iucn.org/resources/commission-statement/iucn-commission-statement-research-involving-species-risk-extinction) and the IUCN policy statement (https://iucn.org/policy) on research involving species at risk of extinction. Voucher specimen for every wild plant covered in a manuscript must be placed in a public herbarium or any other publicly accessible collection in order to guarantee repeatability. Information on the voucher specimen, including who identified it, must be included in manuscripts (https://www.genesispcl.com/for-authors/). This promotes openness and upholds the accuracy of the study results. The specifics of the Plant Rights & Ethics declaration must be made clear in the Materials and Methods section the manuscript.
(f)Misconduct Handling & Complaints Process:
*Misconduct Handling:
The term "research misconduct" includes a wide variety of unethical actions that compromise the reliability of scientific studies. The most common forms of unethical behaviour in research are:
(I) Plagiarism: To plagiarise is to take another author's thoughts or phrases and portray them as one's own original work by wrongfully appropriating and stealing and publishing. IJERR strongly discourages and condemns this kind of unauthorized copying.
Plagiarism is defined as follows:
#Changing the words but replicating the sentence structure of a source without providing a reference is considered plagiarism.
#Copying words or ideas from someone else without providing a reference is considered plagiarism.
#Using someone else's work as one’s own is unethical.
#Putting one’s name on someone else's essay or effort is considered plagiarism.
#Failure to enclose a quote inside quotation marks.
#Falsely identifying the source of a quote.
#Self-plagiarism: Plagiarism occurs when an author presents substantially similar material from their own published works as original work without properly attributing the sources. When dealing with such cases, we follow the rules set out by the COPE.
In a submitted manuscript, there is a possibility of redundant publishing (https://publicationethics.org/search?query=files+duplicate+publication+submitted+manuscript+cope+flowchart.pdf&urlfield=) whereas in a published article, there is a possibility of repetitive publication (https://publicationethics.org/search?query=files+duplicate+publication+published+article+cope+flowchart.pdf&urlfield=).
#Plagiarism cannot be prevented only by altering the terms of a source. No matter how significantly one modifies the context or presentation of a source's basic concept, one has plagiarised it if one has not mentioned it. This is true even if one has kept the source's essential idea. The majority of instances of plagiarism, on the other hand, maybe prevented simply by crediting sources. Plagiarism may typically be avoided by simply declaring that particular content has been taken and giving one’s readers the information they need to locate the original source.
Declaratory statement against plagiarism, upon submitting a work for consideration for publication in IJERR, the author(s) guarantee that:
#Using another person's idea or published work in order to pass it off as one's own is plagiarism, and authors are well aware that doing so is unlawful and bad. They also understand what plagiarism is and how it works. The students are also aware that plagiarism is defined as the intentional appropriation of another person's idea or published work in order to pass it off as one's own.
#To ensure that all sources consulted in the writing of the article or project have been recognized and properly cited, writers, sign a declaration before submitting their work for publication.
#Unless otherwise stated, the author(s) take full responsibility for the work they have done, the material in the article, and any errors or omissions in the citations.
Action is taken against plagiarism as:
(i) A double-blind peer-review process is used to ensure the highest quality and fair policy of evaluation and publication process to maintain the highest ethical standards and avoid plagiarism. Submitted research articles are assessed and reviewed by specialist reviewers (at least two – one from India and one from abroad) as invited for specific disciplines using the double-blind peer review process to ensure the highest quality and fair policy of evaluation and publication process to maintain the highest ethical standards.
(ii) Editorial board members have now double-checked such similarities with the help of the Turnitin plagiarism software.
(iii) Provide the author(s) with precise information.
(II) Fabrication:
Research misconduct includes the fabrication and presentation of fabricated data, results, or methodologies. In the event that any claims, grievances, or discoveries are made concerning falsification, the publishing house will inform the relevant author and ask for an explanation. The publisher will get in touch with the author(s)’ institution or place of employment if they do not receive a suitable response from the author(s). The matter is addressed in keeping with the standards set forth by COPE (https://publicationethics.org/guidance/case/possible-plagiarism-and-fabrication).
(III) Falsification:
Researchers commit research misconduct when they tamper with or withhold data, or when they manipulate study supplies, equipments, or processes in order to falsify the results. The following links detail the protocols proposed by COPE, which are followed when dealing with such matters:
*Before publication: Suspected fabricated data in a submitted manuscript (https://publicationethics.org/search?query=files+fabricated+data+submitted+manuscript+cope+flowchart.pdf&urlfield=)
*After publication: Suspected fabricated data in a published article (https://publicationethics.org/search?query=files+fabricated+data+published+article+cope+flowchart.pdf)
*Figures: Inappropriate image manipulation in a published article (https://publicationethics.org/guidance/flowchart/inappropriate-image-manipulation-published-article)
(IV) Authorship Issues:
Misconduct occurs when proper contributions are not acknowledged or when people who do not fulfill the authorship standards are included as authors. For help in spotting possible authorship problems, COPE (https://publicationethics.org/guidance/flowchart/how-recognise-potential-authorship-problems) offers several suggestions. Once a paper has been accepted, the authorship cannot be changed in any way, including adding or removing authors, changing the corresponding author, or changing the sequence of authors.
(V) Conflict of Interest:
It is considered a conflict of interest when researchers do not reveal any financial or personal relationships that may impact the results of their studies. The following procedures shall be followed for dealing with any instances of conflict of interest:
*Reviewers suspect undisclosed conflict of interest in a submitted manuscript (https://publicationethics.org/search?query=files+conflict+of+interest+submitted+manuscript+article+cope+flowchart.pdf&urlfield=).
*Readers suspect undisclosed conflict of interest in a published article (https://publicationethics.org/search?query=files+conflict+of+interest+publlished+article+cope+flowchart+v2.pdf&urlfield=).
(VI) Manipulation of Citations:
This is the result of academics citing just the papers that back up their claims and disregarding the ones that could disprove them. Misleading narratives and skewed research landscapes might result from this strategy. Furthermore, when authors heavily rely on citing their own work, it can distort the perception of their significance and importance, which in turn undermines the credibility of the literature. Authors are asked to provide a reasonable explanation when something happens. After discussing each situation with the Co-Editors-in-Chief, a final judgement is reached.
(VII) Violation of Research Ethics:
Unethical conduct includes not getting participants' informed consent, breaking their confidentially, or putting them in danger. For the purpose of study subjects' rights and well-being, it is crucial to follow ethical rules. Concerns regarding ethics will be handled in line with COPE's guidelines (https://publicationethics.org/search?query=sites+default+files+ethical+problem+in+submitted+manuscript+cope+flowchart.pdf&urlfield=).
(B) Authorship and Contributorship Policy:
#Authorship carries responsibility and gives researcher credit for their contributions to a study.
#Each author must have contributed significantly to the idea or design of the work, the collection, analysis, or interpretation of data, the development of new software used in the work, the writing of the work, or its considerable revision.
#AND to have given final approval to the version submitted (and any significantly revised version including the author's contribution to the study).
# AND to have agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.
#Colleagues in the areas where the study is being conducted are encouraged to collaborate, and when they meet the above-mentioned requirements for authorship, IJERR expects to include them as co-authors. Those who contributed but didn't match the requirements for authorship should be acknowledged in the acknowledgements section.
#When an article is submitted to an IJERR, the journal assumes that all of the listed authors have approved of the article's contents, including the author list and author contribution statements. The corresponding author is in charge of managing all correspondence between the journal and all co-authors before and after publication. This includes making sure that all authors have approved the manuscript submission to the journal and have agreed to be so listed. On behalf of all authors of the manuscript, the corresponding author must also submit a competing interests statement.
#All information in the proof, including co-authors' names, addresses, and affiliations, is the responsibility of the corresponding author after acceptance.
#After publication, questions about the paper are directed to the corresponding author & co-authors. They are accountable for keeping all co-authors updated on any issues pertaining to the published paper and making sure that issues are resolved quickly. If authors discover any errors in previously published work, they have a duty to notify the journal as soon as possible.
# Final approval of the published version.
#Agreement to take responsibility for all parts of the work, including making sure that any concerns about the integrity or accuracy of any element of it are properly looked into and addressed.
#Changes to the original author after submission are not allowed.
#Changing the authorship is not allowed after acceptance; it may only be done during the review process, and the corresponding author must submit a request form for the change.
(C) Complaints and Appeals Policy:
Although this is not always practicable, the journal is for authors to address such issues between themselves. The complainant must be informed that the problem will not be examined until the journal editor notifies the corresponding author or author and the institution or firm where the study was conducted of the complaint. Unless the author gives an acceptable explanation, the editor should inform the author that the issue may be addressed to the university or firm where the study was conducted and any other relevant institution or organisation (for example, a funding agency). In this fact-finding phase, the editor may want to solicit the opinions and comments of other parties who are likely to be familiar with the facts asserted by the complaint.
(D) Conflicts of interest / Competing interests:
All institutional, private, and corporate funding sources for the study must be disclosed by the authors. Materials donors (free or at a reduced cost from current rates) should be identified in the financing source along with their location (town, state/county, or country). The text will identify other donors. It should be noted at submission if the author's institution is the only source of funding available. Any possible conflicts of interest must also be disclosed by the authors. At any point throughout the publishing process, all authors must disclose any possible conflict(s) of interest, such as when an author has a competing interest (actual or perceived) that might be regarded or seen as having an undue influence on their obligations and/or tasks. In addition, any financial or other substantial conflicts of interest that might be perceived as influencing the findings or interpretation of their paper must be disclosed by all authors in their submission. These include financial interests (such as patents, stock ownership, consultancies, and speaking fees) or the manufacturer's offering of study materials at no cost or a reduced price from the going rate. The sources of financing for the study and the author's conflicts of interest (or information indicating that there are none) will be provided under a separate header called Conflict of Interest and Sources of Financing Statements. Animal & plant studies must be shown to be morally acceptable and, when applicable, must follow national regulations for the use of humans, animals, and plants in research. Before the References section, the Conflict of Interest details must be clearly stated.
(E)Data and Reproducibility:
Authors are requested to make available the data and methodology used to support their findings.
Authors should be willing to make their data publicly available if possible and should submit all raw data associated with their research for editorial assessment. Furthermore, the data have to be kept for a fair amount of time following publishing. A data availability declaration detailing the means and locations of data access is also highly encouraged.
Reproducibility: To make sure that the study can be accurately replicated by others, manuscripts should contain sufficient methodological information.
(F) Post-Publication Discussions and Corrections:
We kindly request that authors instantly notify us of any errors in their published work so that our publications can continue to be accurate and reliable.
Please contact the editorial office as soon as possible at the email or phone numbers listed on the journal's website if you become aware of any mistakes in your published work. For the most part, these kinds of correspondence are meant to be directed at the corresponding author.
Once the notification is received, the editorial staff will review the reported error and any accompanying data. The editor or a representative with relevant expertise will lead this assessment. More than one round of peer review may be required for the suggested fix before it is sent out.
*Mechanics for Correction: The editor will decide how to fix the mistake best. This may need the publication of a Corrigendum to address mistakes that do not undermine the general validity or conclusions of the article. The authors must get approval from all of their co-authors before publishing the Corrigendum, which is their responsibility to prepare.
In the event that a mistake arises during publication and needs to be rectified, the journal has the authority to publish an erratum. An erratum will be attached to the paper for the purpose of elucidating any errors without influencing the main findings of the study.
*Retraction: The journal has the right to retract an article if major problems are found, such as major plagiarism, misconduct, or severe errors that cast doubt on the results. An explanation of the retraction and its rationale will be provided to readers in a retraction notice that will be published. The journal will make sure that the retracted work is clearly marked as such, but it will still be available.
(G)Intellectual Property Policy:
(I) Copyright & Access Policy:
# The simple act of submitting an unpublished manuscript does not constitute a violation of any copyright or trademark.
# When the manuscript is accepted for publication, the author(s) automatically agrees to transfer the copyright to the publisher.
# All author(s) jointly declare that the text is original, that it does not infringe on any copyright or violate any other third-party right, and that it has not been published or is being considered for publication anywhere.
# All authors agree to the terms and conditions set out by the IJERR (e-ISSN: 2455-4855) and acknowledge that the journal has the right to retract any published paper if misconduct is discovered.
# All authors must ensure that the manuscript has been prepared to ensure the highest ethical standards and are solely responsible for the originality of the contents.
(I) Copyright & Access Policy:
Facilitating the sharing and building of others' work in a way that is in keeping with copyright regulations is a primary goal of the International Academic Publishing House (IAPH). Utilising a particular Creative Commons license, we offer usage rights, allowing the Open Access paradigm to function as intended—that is, as free, online access with usage rights. All of the work produced on this website of the publisher (www.iaph.in) is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
After their work appears in the journal, authors can freely disseminate a preliminary version of their paper to any online repository thanks to this license.
Meeting all requirements The "CC BY" license facilitates reading and downloading, displaying in a repository, translating, and commercial uses of the manuscript.
The acronym "CC" denotes a Creative Commons license. The usage of the "BY" symbol indicates that users have acknowledged the original author and are free to use or share the published texts. Any kind of redistribution, for profit or not, is permissible under this license so long as the work is properly attributed and not altered in any way.
(III) Ownership and Management:
The International Academic Publishing House (IAPH) owns the International Journal of Experimental Research and Review (IJERR) (e-ISSN: 2455-4855). The journal is managed by a dedicated team of experienced academic researchers who are guided by the editorial and advisory boards. The journal's major purpose is to close the gap between research and practice by encouraging and publishing original articles.
On the editorial board, please visit: https://qtanalytics.in/journals/index.php/IJERR/editorial-board
- International Academic Publishing House (IAPH) has 3 major principles in scholarly publishing:
#The independence of Editorial Board members, especially both the Co-Editor-in-Chief, in making scientific decisions;
#Performing appropriate peer-review model for selecting scholarly materials, when submitting the paper online, it is required to include a Cover letter cum Declaration form in which the author should essentially highlight the topics of their research. Searching for reviewers' names from a variety of sources will be helpful to editors. ; and
#The structural consistency of published materials that helps the readers and researchers to recover and use them easily;
- International Academic Publishing House (IAPH) has tried to resist all parameters that conflict with these principles and also make all the participants of scholarly material production aware of the consequences of deviation from these principles.
- The following are International Academic Publishing House (IAPH) guidelines for protecting the responsibility and authority of both the Co-Editor-in-Chief and owners:
- The conditions of both the Co-Editor-in-Chief's employment, including authority, responsibilities, term of appointment, and mechanisms for resolving conflict, are explicitly stated and approved by both the editor and owners before the editor is appointed.
- Both the Co-Editor-in-Chief have full authority over the journal's editorial content, generally called "editorial independence." Owners do not interfere in evaluating, selecting, or editing individual articles directly or by creating an environment in which editorial decisions are strongly influenced.
- Editorial decisions are based mainly on the validity of the work and its importance to readers, not the journal's commercial success. - Editors are free to express critical but responsible views about all aspects of medicine without fear of retribution, even if these views might conflict with the publisher's commercial goals. To maintain this position, editors seek input from various advisors, such as reviewers, editorial staff, an editorial board, and readers.
- Both the Co-Editor-in-Chief establish procedures that guard against the influence of commercial and personal self-interest on editorial decisions.
- Owners have the right to hire and fire both the Co-Editor-in-Chief, but they dismiss them only for substantial reasons, such as a pattern of irresponsible editorial decisions, scientific misconduct, disagreement with the journal's long-term editorial direction, or personal behavior (such as criminal acts) that are incompatible with a position of trust. Furthermore, any evaluation on which hiring or firing is based should be performed by a panel of independent experts rather than a small number of executives of the owning organization.
- Both the Co-Editor-in-Chief report to the highest governing body of the owning organization, not its administrative officers. This body makes major decisions regarding the editor's employment with open discussion and time to hear from all interested parties. Some owners have found it useful to appoint an independent board to advise them on major decisions regarding their editor and journal.
- Editors resist any actions that might compromise these principles in their journals, even if it places their position at stake. If major transgressions do occur, editors participate in drawing them to the attention of the international medical community.
- The owners of journal published by International Academic Publishing House (IAPH) are mainly academic Publisher.
- The owners' details are clearly specified on each journal's website.
International Academic Publishing House (IAPH) has tried to resist all parameters that conflict with these principles and also make all the participants of scholarly material publication. The three main principles in scholarly publishing are-
#The independence of Editorial Board members, especially both the Co-Editor-in-Chief, in making scientific decisions;
#The International Academic Publishing House (IAPH) policies below help to safeguard the power and accountability of owners as well as the Co-Editor-in-Chief.
#The structural uniformity of published materials that facilitates users' and researchers' easy recovery and usage
Before the editor is chosen, both the editor and owners clearly define and approve the terms of appointment, authority, responsibilities, and conflict-resolving policies of both the Co-Editor-in-Chief's employment.
Generally referred to as "editorial independence," both the Co-Editor-in-Chief have complete control over the editorial content of the publication. Owners neither personally evaluate, choose or edit specific articles nor create a climate whereby editorial decisions are highly impacted.
Editorial decisions are mostly based on the quality and validity of the work and its relevance to readers, not on the monetary success of the journal. Even if these points of view can contradict the publisher's business objectives, editors are free to offer critical but responsible opinions about all facets without regard to consequences. Editors consult several advisers—including reviewers, editorial staff, an editorial board, and readers—to keep this posture.
The both co-editor-in-chief set policies that prevent editorial decisions from being influenced by personal or economic self-interest.
One could say that although owners have the right to hire and fire the Co-Editor-in-Chief, they dismiss them only for very specific reasons—such as a pattern of careless editorial decisions, scientific misbehaviour, disagreement with the journal's long-term editorial direction, or personal behaviour (such as criminal activities) incompatible with a position of trust. Moreover, any assessment on which hiring or dismissal is based should be conducted by a panel of unbiased professionals instead of a Co-Editor-in-Chiefs and Associate Editors of the owning Publishing House.
In particular, not its administrative officials, both the Co-Editor-in-Chief answer to the highest governing body of the holding Publishing House. Major decisions on the editor's employment are made by this body under open discussion and with time to consult all relevant parties. Appointing an independent board to guide owners on important decisions about their editor and journal has proved helpful.
In particular, even if it puts their job at risk, editors object to any activities in their journals that would jeopardise these values. Should significant violations take place, editors help to bring them to the attention of the Publisher.
For this Journal produced by International Academic Publishing House (IAPH) has mostly academic publishers as proprietors. We highlighted every item of data/ information on the website that exactly reveals the details of the owners.
(H) Additional Archiving, Abstracting & Indexing:
# Many open-access public archives are obligated to keep all supporting data in publications that are published by the International Academic Publishing House (IAPH) and its journal (International Journal of Experimental Research and Review, e-ISSN: 2455-4855).
# Authors may download their papers, as well as linked articles, in PDF format at any time from the IAPH journal's website (www.iaph.in).
# IAPH also uploads all the published articles in many digital libraries viz., Internet Archive library, and other social networking websites such as Academia.edu and other global indexing websites.
# At present the Journal is indexed and abstracted in many databases viz., Crossref, Google Scholar, EuroPub, Academia.edu, Index etc.
(I) Repository Policy :
International Journal of Experimental Research and Review (www.iaph.in) has a policy that allows authors to submit all versions of their articles to any repository they choose. Besides these, the Journal of the Publisher is recorded in PKP (Public Knowledge Project; https://pkp.sfu.ca/software/ojs/ ) continuously. All submitted articles are reposited on PKP-OJS journal online storage (Cloud). Secondarily, these files are copied and stored on the Publisher’s Mother website (www.iaph.co.in). Accepted manuscripts are also stored in the Copyediting section of the PKP-OJS system and the Publisher's Mother website. Published articles are also repositioned at the Galley of PKP-OJS system, Publisher Mother website, Internet Archive, Euro Pub, Academia Edu etc.
The open-access options allowed by the journal's policy are listed below based on the version of the article:
# Published Version:
Embargo: No Embargo
Licence: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0
International License.
Copyright Owner: Publisher & Author(s)
Location(s): -Any Repository including Social Media, Libraries etc.-Author’s,
Journal & Publisher Homepage Conditions: -Must be Cited and Acknowledged
# Accepted Version:
Embargo: No Embargo
Licence: Nil
Copyright Owner: Author(s)
Location(s): -Journal online Repository system (PKP/OJS system)
Conditions: -Must be Cited and Acknowledged
# Submitted Version:
Embargo: No Embargo
Licence: Nil
Copyright Owner: Author(s)
Location(s): -Journal online Repository system (PKP/OJS system)
Conditions: -NA
(J) Advertising Policy:
# International Journal of Experimental Research and Review (IJERR) and its Publisher [International Academic Publishing House (IAPH)] do not accept advertising on its official website (https://www.iaph.in). IJERR & IAPH neither endorses the advertised company or product nor allows advertising to affect editorial decisions or content.
#IJERR & IAPH reserve the right to refuse any advertisement incompatible with our mission. The journal's editorial board does not evaluate or publish any advertising-related articles (both on a reimbursable and free basis). The following types of advertisements are prohibited also from the articles-
*Political and religious advertisements
*Advertisements that claim to offer a miracle cure or method
*Advertisements for alcohol, tobacco or any related product(s)
*Advertisements for weapons, firearms, ammunition and fireworks
*Advertisements for pornography and related materials and services
*Advertisements that make unsubstantiated health claims for the products advertised
# A product or service that is identified as an advertisement or that is promoted by a sponsor in publications is not supported by the International Journal of Experimental Research and Review (IJERR) or the International Academic Publishing House (IAPH).
#Neither advertisers nor their agents may collect personal information from any user viewing the IJERR website (www.iaph.in) except with the user's knowledge and permission and only after giving the user substantive information about the uses to which the information will be put.
# There must be no advertising-related terms used by the author in the keyword section. Any advertising complaints should be sent to:
iaphjournal@gmail.com
Address:
Manoranjan Madhu
Publisher, International Academic Publishing House (IAPH)
Address: Vill. & P.O. Thakurnagar 743287, North 24 Parganas, West Bengal, India
E-mail: iaphjournal@gmail.com
Shubhadeep Roychoudhury, Ph.D., Habil.
Co-Editor-in-Chief
Associate Professor, Department of Life Science & Bioinformatics
Assam University, Silchar 788011, India
E-mail: shubhadeep1@gmail.com, editoriaph@rediffmail.com
Nithar Ranjan Madhu, Ph.D.
Co-Editor-in-Chief
Nibedita Park, Sarada Sarani,
P.O. Barasat, Pin 700127, Dist. North 24 Parganas, West Bengal, India
E-mail: chiefeditoriaph@gmail.com, nithar@apccollege.ac.in
Dr. Jayati Chakrabarti Mallick, Ph.D.,
Associate Editor
Associate Research Investigator & Scientist IV, Zavros Lab
Department of Cellular & Molecular Medicine
University of Arizona College of Medicine, Tucson, USA
E-mail: chakraj@arizona.edu, chakraj@email.arizona.edu
Dr. Jayanta Das, Ph.D.
Associate Editor
Assistant Professor of Biology, Florida Memorial University, Florida, USA
E-mail: jayanta.das@fmuniv.edu
